Skip to content

A comparison of dexamethasone, pethidine and ketamine in the prevention of postoperative shivering

A comparison of dexamethasone, pethidine and ketamine in the prevention of postoperative shivering in patients undergoing general anesthesia.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017012232100N1
Enrollment
164
Registered
2017-07-04
Start date
2016-07-31
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Prevention of postoperative shivering. Condition 2: Postoperative shivering in general anaesthesia. complication of surgical and medical care, unspecified complication of surgical and medical care, unspecified

Interventions

Intervention 1: Group A will receive dexamethasone 0.15 mg/kg intravenously. Intervention 2: Group B will receive ketamine 0.5 mg/kg intravenously. Intervention 3: Group C will receive pethidine 0.5
Prevention
Placebo
Group A will receive dexamethasone 0.15 mg/kg intravenously.
Group B will receive ketamine 0.5 mg/kg intravenously.
Group C will receive pethidine 0.5 mg/kg intranenously.
Group D will receive normal saline 2 ml intravenously.

Sponsors

Vice Chancellor for Research of Gonabad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: The patients must: be between 20-60 years old; undergo general anaesthesia; be willing to participate in the study; filling in the informed consent form; not have cardiac nor pulmonary diseases; not have thyroid dysfunction; be healthy; not be allergic to the prescribed medicines; not suffer from Parkinson’s disease; dysautonomia nor rhynod syndrome; not drink alcohol; not use vasodilator; and not suffer from neurologic nor psychological disorders. Exclusion Criteria: Transfusion during surgery; malignant Hyperthermia; having central temperature less than 5.36 degrees centigrade or higher than 38 during operation; and the occurrence of any kind of clinical outcome or condition that prevents the patient’s postoperative evaluation.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Shivering. Timepoint: Postoperative. Method of measurement: Checklist.;Shivering after general anaesthesia. Timepoint: 10 minutes. Method of measurement: Observation.

Secondary

MeasureTime frame
Pain. Timepoint: Postoperative. Method of measurement: Checklist.;Hallusination. Timepoint: Postoperative. Method of measurement: Checklist.;Diastolic blood pressure. Timepoint: Every 15 minutes before anaesthesia induction until one hour after the end of operation. Method of measurement: Sphygmomanometer.;Systolic blood pressure. Timepoint: Every 15 minutes before anaesthesia induction until one hour after the end of operation. Method of measurement: Sphygmomanometer.;Delirium. Timepoint: Postoperative. Method of measurement: Checklist.;Nausea, Vomiting. Timepoint: Postoperative. Method of measurement: Checklist.;Body temperature. Timepoint: Every 15 minutes before anaesthesia induction until one hour after the end of operation. Method of measurement: Thermometer.;Environment tempreture. Timepoint: Every 15 minutes before anaesthesia induction until one hour after the end of operation. Method of measurement: Thermometer.;Heartbeat. Timepoint: Every 15 minutes before anaesthesia induction until one hour after the end of operation. Method of measurement: Pulse Oximeter.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSepideh Sedaghati Ansari

Gonabad University of Medical Sciences

sepideh.sedaghati74@gmail.com+51 57 236833

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026